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Abstract 
Remodeling of actin and microtubule cytoskeletons is thought to be coupled; however, the interplay 
between these two systems is not fully understood. We show a microtubule end-binding protein, EB1, is 
required for formation of polarized morphology and motility of melanoma cells.  EB1 depletion 
decreased lamellipodia protrusion, and resulted in loss of opposed protruding and retracting cell edges.  
Lamellipodia attenuation correlated with mis-localization of filopodia throughout the cell and decreased 
Arp3 localization.  EB1-depleted cells displayed less persistent migration and reduced velocity in single-
cell motility experiments. We propose EB1 coordinates melanoma cell migration through regulating the 
balance between lamellipodial and filopodial protrusion.   
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1. Introduction 
Cell motility is a complex process requiring coordinated re-organization of actin and microtubule 
cytoskeletons in both physiological and pathological conditions including angiogenesis and tumor cell 
metastasis.  Filopodia and lamellipodia are protrusive structures localized to the cell front during 
motility [1], the activity of which is coordinated with trailing edge release from adhesive substrate [2]. 
These protrusive structures are regulated through the signaling molecules RhoA, Rac and Cdc42, and 
regulators of actin network organization including factors promoting actin filament nucleation and 
bundling [3-5]. Microtubules cooperate with the actin cytoskeleton to maintain cell polarization at 
leading and trailing edges during cell migration, and to remodel adhesive contacts with extracellular 
matrix protein [6,7]. Function of microtubules are controlled or mediated through microtubule plus-end 
tracking proteins [8] which bind preferentially to the growing microtubule plus-ends [9].  
Polymerization of microtubules into the cell cortex place plus-end tracking proteins in a spatial 
context for mediating cross-talk with the protrusive actin cytoskeleton.  A major group of plus-end 
tracking proteins is the EB1 family, comprised of human members with representative homologs in 
yeast and other organisms [10]. The N-terminus of EB1 protein contains a calponin homology domain 
that mediates binding to microtubules [11] followed by a coiled-coil domain responsible for 
dimerization [12]. EB1 proteins are known to control specific microtubule dynamic parameters. For 
example, EB1 promotes microtubule growth through increased rescue frequency and decreased 
catastrophe of plus-ends [13,14]. Yeast homologues of EB1 increase dynamic behavior of microtubules 
and decrease pausing of microtubule growth [15,16]. EB1 interacts with other plus-end tracking proteins 
[8] and controls accumulation of cytoplasmic linker proteins to microtubule ends [17].  
EB1 was initially described as a binding partner of adenomatous polyposis coli (APC) [18], a 
tumor suppressor factor associated with colorectal cancer [19]. The EB1 C-terminal domain is 
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responsible for binding the C-terminal domain of APC [20]. Most of the APC mutations associated with 
colorectal cancer result in protein truncation [21], and thereby loss of EB1 interaction. EB1 is 
differentially expressed in various types of tumors and is associated with malignant phenotype. EB1 
expression is increased in patient samples and cell lines from hepatocellular [22], esophageal [23], and 
human gastric [24] carcinomas; however, EB1 is decreased in pediatric ependymomas [25]. EB1 
overexpression promotes cellular growth, activation of the beta-catenin/T-cell factor pathway and 
increases tumor formation [23,26].  Here we address the role of EB1 protein in actin protrusion 
dynamics and motility in mouse melanoma cells. 
 
2. Materials and Methods 
2.1 Cell culture and reagents 
 B16F1 mouse melanoma cells were purchased from American Type Culture Collection, 
Manassas, VA, USA  and maintained in DMEM (Gibco Invitrogen, Carlsbad, CA, USA) supplemented 
with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA, USA) and antibiotics.  
Trypsin/EDTA solution (Mediatech, Manassas, VA, USA) was used for cell detachment.  Cells were 
transfected using Fugene 6 reagent according to manufacture protocol (Roche Diagnostics). Phalloidin 
conjugated to Alexa Fluor 350 was from Molecular Probes Invitrogen; rabbit affinity purified anti-Arp3 
was from Millipore Corporation; mouse anti-fascin was from Santa Cruz Biotechnology, Inc, and mouse 
anti-EB1 was from BD Transduction Laboratories.  TRITC-conjugated anti-mouse antibodies were from 
Jackson ImmunoResearch Laboratories; Alexa Fluor 488- conjugated anti-mouse and Alexa Fluor 647-
conjugated anti-rabbit were from Molecular Probes Invitrogen.   
 
 
5 
 
2.2 RNA interference 
 The target sequence used for knock down of EB1 protein expression was 
GCCTGGACCAGCAGAGCAA (EB1 KD) and the two-nucleotide mismatch control sequence was 
GCCTGGACAAGCAGGGCAA (MM control).  The target and MM control sequences were inserted 
into pGShin vector [27] and B16F1 cells were transfected using Fugene 6 reagent according to the 
manufacturer instructions.  Experiments were performed 3 days after addition of vector when EB1 
depletion averaged 92% in the transfected cell population identified by GFP co-expression [28].   
 
2.3 Immunofluorescence microscopy 
 B16F1 cells transfected with EB1 or two-nucleotide mismatch control (MM control) shRNA 
constructs were plated onto glass coverslips coated with 30µg/ml mouse laminin (Invitrogen) for 24 
hours at 4ºC and blocked with 2% bovine serum albumin.  High refractive-index coverslips (Optical 
Analysis Corporation, Nashua, NH, USA) were used for total internal reflection fluorescence studies.  
For phalloidin staining, samples were fixed in phosphate-buffered saline (PBS) containing 1% 
glutaraldehyde and 0.5% Triton-X 100 for 20 minutes at room temperature. For EB1, fascin and Arp3 
immunostaining cells were fixed in -20ºC methanol followed by post-fixation with 4% formaldehyde in 
PBS containing 0.1% Triton-X 100 for 10 minutes.  Coverslips were mounted with Aqua poly/mount 
(Polysciences, Warrington, PA, USA).   Total interval reflection fluorescence microscopy was 
performed on an Olympus IX70 inverted microscope equipped with an Apo 100X, 1.65 NA oil 
immersion objective and a 12-bit depth cooled CCD camera.  All other fluorescence images were 
acquired using a Nikon Eclipse TE200 and Leica DMIRE2 HC microscopes fitted with 16-bit CCD 
cameras.  For analysis of cell spreading and roundness index, threshold was applied to digital images of 
phalloidin fluorescence using Metamorph imaging software (Universal Imaging, Westchester, PA, 
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USA).  The pixel areas of the objects (cells) created from the threshold images were converted to µm2.  
The roundness index is the measured cell area divided by the area of a circle with a diameter equal to the 
longest chord through the cell.  Line scan intensity analysis over the cell edge was performed on 16-bit 
images using Metamorph software.  Z-series images were acquired at 0.5 µm-increments, deconvolved 
to reduce out-of-focus fluorescence and reconstructed using Metamorph.  For presentation, images were 
rescaled and converted to 8-bit depth using Adobe Photoshop (Adobe Systems, Mountain View, CA, 
USA).  
 
2.4 Live cell imaging and motility assay. 
 B16F1 cell spreading and single cell motility experiments were performed using the Delta T 
temperature control dish system (Bioptechs, Butler, PA, USA).  Humidified air with 5% CO2 was 
infused into the enclosed system and temperature was maintained at 37ºC using the heated dish and lid 
system regulated by the Delta T4 controller (Bioptechs). Phase contrast images were acquired with a 
Leica DMIRE2 HC inverted microscope using 10X or 20X phase objectives. Cells were plated onto 
laminin at low density and images were acquired every 2.5 minutes for 78 minutes for analysis of cell 
edge protrusion and every 30 minutes for 22.5 hours for analysis of cell body displacement. For 
determination of cell edge protrusion velocity, kymographs were constructed and analyzed using 
Metamorph software.  Protrusion velocity was taken as edge displacement in microns during the first 30 
minutes of cell spreading.  Cell migration was taken as displacement of the nucleus center in microns 
over 22.5 hours.  Threshold for nucleus displacement was 1.7 µm.  Average velocities over 22.5 hours 
for multiple cells were determined by linear regression analysis.  
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3. Results 
3.1 EB1 knock down delays cell spreading and alters cell shape change.  
 We transfected B16F1 mouse melanoma cells with a plasmid encoding a short hairpin RNA 
(shRNA) sequence specific for EB1 or a two-nucleotide mismatch control sequence. Co-expression of 
soluble GFP allowed identification of transfected cells [27]. We achieved 92% depletion of EB1 protein 
in GFP-positive B16F1 cells as assessed by quantitative immunofluorescence on microtubule plus-ends 
[28]. Cells expressing EB1 knock down (EB1 KD) or two-nucleotide mismatch control (MM control) 
constructs were plated onto laminin, and fixed after 0.5, 1.0, 2.0 or 4.0 hours for assessment of cell 
spreading and polarization (Figure 1A). Roundness index, a measure of polarized cell morphology, was 
expressed as the ratio of projected cell area to the area of a circle with a diameter of the longest cord 
through the cell. Thus, a circular cell has a roundness index of 1.0 and a highly elongated cell 
approaching 0.  Depletion of EB1 resulted in decreased cell area for up to 2.0 hours compared to cells 
expressing MM control sequence suggesting EB1 protein is involved in the rate of cell spreading (Figure 
1B). Furthermore, EB1 depleted cells maintained circular shape over the whole time course, whereas 
cells expressing MM control shRNA and non-transfected cells underwent transition from circular to 
elongated shape (Figure 1A, C) suggesting EB1 protein is required for formation of polarized cell 
morphology. The loss of cell polarization in EB1 depleted cells may therefore correlate with defects in 
migration. 
 
3.2 Depletion of EB1 decreases net protrusion and slows motility. 
 We next evaluated the effect of EB1 depletion on lamellipodia protrusion using phase contrast 
imaging of live cells. The analysis was performed for 78.0 minutes during which MM control and 
control cells spread uniformly for a period of 20-30 minutes followed by formation of distinct 
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protruding and retracting edges (Figure 2A, B).  By contrast, EB1 depleted cells failed to form opposed 
protruding and retracting edges (Figure 2C).  When dynamics of lamellipodia were analyzed using 
kymographs (Figure 2D), velocity of the advancing edge was significantly decreased in EB1 knock 
down cells consistent with the decreased cell area shown in Figure 1. The average velocity of edge 
protrusion was decreased by nearly 50% in EB1 depleted cells compared to controls (Table I). These 
data suggest that EB1 may positively regulate lamellipodia formation.  
 Study using a single-cell motility assay addressed the role of EB1 in cell migration. We tracked 
2-dimensional translocation of individual cells on laminin for a period of approximately 24 hours. 
Figure 3A shows individual tracks in microns of non-transfected, EB1 KD and MM control cells.  
Motility of the EB1 depleted cell was substantially reduced compared to the cell expressing MM control 
shRNA and the non-transfected cell. Movement of multiple cells was averaged and converted to plots of 
cumulative distance traveled (Figure 3B) and distance from cell origin (Figure 3C). Average cell body 
velocity and distance from origin of EB1 KD cells was decreased approximately 40% and 70%, 
respectively, compared to MM control (Table I). 
 
3.3 Enhanced filopodia and attenuated lamellipodia formation in EB1 depleted cells.  
 We examined whether disrupted actin protrusive activity in EB1 KD knock down cells was 
accompanied by imbalance between lamellipodia and filopodia formation. We used 
immunofluorescence staining of fascin, a marker of filopodia [29], and Arp3, a marker of lamellipodia 
[30] to determine localization and abundance of these structures. We found filopodia localized to what 
appeared to be the ventral surface of EB1 KD cells, whereas filopodia were restricted to the periphery in 
non-transfected cells (Figure 4A). The average number of filopodia per cell was increased at least two-
fold in EB1 KD cells compared to non-transfected cells in the same (Figure 4B) or independent culture 
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(11.2 +/- 3.8 filopodia/cell at 30 minutes, n=19 cells).  To confirm whether the filopodia in EB1 KD 
cells were projected from the ventral surface we used total internal reflection fluorescence (TIRF) 
microscopy [31]. The majority of the fascin-positive structures observed by wide field were also visible 
by TIRF microscopy (Figure 4C), indicating abnormal filopodia localization at the ventral surface in 
cells depleted of EB1. Acquisition of z-series through EB1 KD cells shows fascin-positive structures 
throughout the entire z-axis (Figure 4D).  Arp3 was concentrated at the cell edge in both non-transfected 
and MM control cells; however, Arp3 fluorescence signal was significantly attenuated in EB1 depleted 
cells (Figure 5A).  Line scan analysis over the cell edge demonstrated that Arp3 accumulation was 
decreased by approximately 50% in EB1 depleted cells compared to non-transfected and MM control 
cells (Figure 5B, C).  These results show depletion of EB1 in melanoma cells causes increased 
production of filopodia and mis-localization of filopodia throughout the cell surface accompanied by 
down regulation of protrusive lamellipodia marked by Arp3 protein.  
 
4. Discussion 
 EB1 protein is over expressed in several types of carcinoma [22-24] and binds to the C-terminal 
domain APC [20].  Since most of the mutations in APC associated with malignancy result in C-terminal 
truncation, binding with EB1 is lost raising the possibility that this interaction is an important part of the 
tumor suppressor function of APC.   APC knock down and domain truncation interfere with cell 
migration, protrusion and stabilization of microtubules [32].  Furthermore, APC interaction with 
microtubules and EB1 is important for microtubule stabilization and cell protrusive activities  [32,33].  
Our results show that depletion of EB1 protein interferes with net lamellipodial protrusion and cell body 
translocation. The effect of EB1 knock down on cell migration is likely the result of inability of cells to 
spatially regulate intracellular signaling events needed for polarization.  Another striking feature of the 
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knock down cells is increased number and mis-localization of filopodia.  In fibroblasts and B16F1 cells, 
Arp2/3 is normally excluded from filopodia [34], reflecting the fundamental difference between the 
molecular machinery of lamellipodia and filopodia protrusion. Cell movement requires optimal balance 
between these two modes of protrusion which is variable among cell types.  For example, growth cones 
contain high density of filopodia [35], while fish keratocytes are devoid of filopodia [36].   B16F1 cell 
motility is intermediate, displaying both filopodia and lamellipodia modes of protrusion [1]. Shift in the 
balance can result in significant decrease in net protrusion [37].  Our results show EB1 is required to 
maintain balance between formation of lamellipodia and filopodia.  Depletion of EB1 shifts the balance 
in favor of filopodial protrusion which likely interferes with overall cell body migration. The signaling 
mechanism of this regulation remains unclear.  EB1 may control actin dynamics through regulation of 
fascin and Arp activity.  For example, EB1 may regulate filopodia formation through altering fascin 
phosphorylation by protein kinase C [38,39] or regulate activity of Arp2/3 complex at lamellipodia 
protrusions [40].  In this regard, EB1 may control lamellipodia formation through regulation of 
microtubule-dependent transport of WAVE2 to cell protrusions [41,42]. Fascin expression is increased 
in various carcinomas [43] and Arp 2/3 expression correlates with invasiveness of colorectal tumor cells 
[44] and progression of gastric carcinoma [45].  Our current study combined with these published 
reports raise the intriguing possibility that EB1 regulates activity of fascin and Arp3 in a cell motility 
signaling pathway controlling melanoma metastasis.  
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Fig. 1.  EB1 knock down delays cell spreading and alters cell shape change. (A) B16F1 cells transfected 
with EB1 (EB1 KD) or mismatch sequence (MM control) shRNA constructs were plated onto laminin 
for the times indicated and were stained with Alexa Fluor 350-phalloidin (red). GFP (green) identifies 
cells transfected with shRNA constructs. Scale bar: 40 μm. (B) Plot of change in projected area of cells 
expressing EB1 KD or MM control shRNA, and non-transfected (control) cells. (C) Plot of change in 
shape (roundness index) of EB1 knockdown and control cells. EB1 knockdown cells maintain a non-
polarized shape over 4 hours (*p<0.05, **p<0.01 unpaired t-test comparing EB1 KD to MM control). 
Error bars: SEM 
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Fig. 2.  EB1 knock down interferes with formation of protruding and retracting cell edges. 
Representative time-lapse sequences of B16F1 cells transfected with MM control (A), non-transfected 
cells (B) and cells transfected with EB1 KD (C). GFP fluorescence is shown. (D) Kymograph analysis 
along the line (indicated at 0.0 minutes) of corresponding cells shown in A, B and C. Arrowheads and 
asterisks indicate protrusive and retracting edges, respectively.  Kymographs were traced for clarity.  
Cell edge protrusion velocities obtained from kymographs are presented in Table I. Scale bar: 30 µm. 
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Fig. 3.  EB1 knock down slows B16F1 cell migration. (A) Representative tracks of individual non-
transfected (control), MM control and EB1 KD cells at 30-minute time intervals over 22.5 hours. 
Cumulative distance traveled (B) and the distance from origin (C) of multiple cells. Average cell body 
velocities and final displacements from origin are presented in Table I.  Error bars: SEM (n=11 cells 
non-transfected and EB1 KD; n=8 cells MM control). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
Fig. 4.  Distribution of fascin in EB1 knock down cells. (A) Distribution of fascin immunofluorescence 
in EB1 KD and non-transfected cells on laminin for the times indicated. EB1 KD cells (asterisks) are 
identified by negative immunofluorescence staining for EB1 (not shown).  Insets show enlarged regions 
of fascin staining in EB1 KD cells. Arrowheads indicate normal localization of fascin at the periphery of 
non-transfected cells.  Scale bar: 40 µm. (B) Number of fascin-positive structures per cell for EB1 KD, 
MM control and non-transfected (control) cells (n=14-20 cells/bar). **p<0.01 unpaired t-test compared 
to MM control and non-transfected cells, error bars: SEM. (C) Representative wide field and total 
internal reflection fluorescence (TIRF) images of fascin in EB1 KD cells after 30 minutes on laminin. 
Scale bar: 10 µm. (D) Z-axis distribution of fascin immunofluorescence in EB1 KD, MM control and 
non-transfected cells (control) cells. Scale bar: 2 µm.  
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Fig. 5.  Distribution of Arp3 in EB1 knockdown cells.  (A)  Arp3 immunofluorescence of 
representative EB1 KD, MM control and non-transfected cells at 0.5 hours.  Asterisks indicate cells 
transfected with EB1 KD or MM control shRNA.  Arrowheads indicate position of linescan over cell 
edge.  Scale bar: 40 µm.  (B)  13-micron linescan of Arp3 immunofluorescence intensity (arbitrary 
units) over edge of MM control (MM), non-transfected (Control) and EB1 knock down (EB1 KD) cells 
in Panel A.  (C) Average Arp3 fluorescence intensity (arbitrary units) over edge of multiple cells 
(**p<0.01 unpaired t-test compared to MM control and control, n = 8-10 cells in each group, error bars: 
SEM). 
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Table I. Cell Motility Parameters 
Parameter EB1 KD MM Control Control 
Edge Protrusion# 
(µm/min +/- s.e.m.) 
**0.27 +/- 0.02 0.52 +/- 0.06 0.47 +/- 0.04 
Cell Body Velocity† 
(µm/hour +/- s.e.m.) 
**15.2 +/- 0.30 25.5 +/- 0.27 28.6 +/- 0.12 
Final Cell Displacement 
from Origin‡ 
(µm +/- s.e.m.) 
*50.1 +/- 12.3 164.0 +/- 30.4 193 .0 +/- 15.1 
# velocity of cell edge protrusion averaged over initial 30 minutes of spreading; † velocity of cell body 
displacement averaged over 22.5 hours; ‡ average of final cell body displacement from origin after 
migration for 22.5 hours; *p < 0.01 and **p  < 0.001 EB1 KD compared to MM control and control; n = 
11-12 cells 
 
